Chronic activation of γ2 AMPK induces obesity and reduces β cell function

Chronic activation of γ2 AMPK induces obesity and reduces β cell function

Despite significant advances in our understanding of the biology determining systemic energy homeostasis, the treatment of obesity remains a medical challenge. Activation of AMP-activated protein kinase (AMPK) has been proposed as an attractive strategy for the treatment of obesity and its complicat...

Bibliografski detalji
Glavni autori:	Yavari, A, Stocker, C, Ghaffari, S, Wargent, E, Steeples, V, Czibik, G, Pinter, K, Bellahcene, M, Oliver, P, Stockenhuber, A, Nguyen, C, Lazdam, M, Kyriakou, T, Parnis, J, Sarma, D, Katritsis, G, Wortmann, D, Harper, A, Brown, L, Peirson, S, Redwood, C, Watkins, H, Ashrafian, H
Format:	Journal article
Izdano:	Cell Press 2016

Slični predmeti

Mutation of Fnip1 is associated with B-cell deficiency, cardiomyopathy, and elevated AMPK activity.
od: Siggs, O, i dr.
Izdano: (2016)

Subunit composition of AMPK trimers present in the cytokinetic apparatus: Implications for drug target identification.
od: Pinter, K, i dr.
Izdano: (2012)

Subunit composition of AMPK trimers present in the cytokinetic apparatus Implications for drug target identification
od: Pinter, K, i dr.
Izdano: (2012)

Embryonic expression of AMPK γ subunits and the identification of a novel γ2 transcript variant in adult heart
od: Pinter, K, i dr.
Izdano: (2012)

Embryonic expression of AMPK γ subunits and the identification of a novel γ2 transcript variant in adult heart.
od: Pinter, K, i dr.
Izdano: (2012)

Citric acid cycle intermediates in cardioprotection.
od: Czibik, G, i dr.
Izdano: (2014)

Mammalian γ2 AMPK regulates intrinsic heart rate
od: Yavari, A, i dr.
Izdano: (2017)

DEVELOPMENT AND CHARACTERISATION OF A NOVEL KNOCK-IN MODEL OF PRKAG2 CARDIOMYOPATHY
od: Yavari, A, i dr.
Izdano: (2009)

Localisation of AMPK γ subunits in cardiac and skeletal muscles.
od: Pinter, K, i dr.
Izdano: (2013)

Localisation of AMPK γ subunits in cardiac and skeletal muscles
od: Pinter, K, i dr.
Izdano: (2013)

Resistance of dynamin-related protein 1 oligomers to disassembly impairs mitophagy, resulting in myocardial inflammation and heart failure
od: Cahill, T, i dr.
Izdano: (2015)

P387Knock-in mouse model of PRKAG2 cardiomyopathy (R299Q) exhibits altered Ca2+-dependent cardiac contractility and reduced protein kinase A activity.
od: Turtle, C, i dr.
Izdano: (2014)

The role of adenosine A2A receptor signalling in cardiac fibrosis
od: Stockenhuber, A, i dr.
Izdano: (2015)

AMP-Activated Protein Kinase Phosphorylates Cardiac Troponin I and Alters Contractility of Murine Ventricular Myocytes
od: Oliveira, S, i dr.
Izdano: (2012)

AMP-Activated protein kinase phosphorylates cardiac troponin i and alters contractility of murine ventricular myocytes
od: Oliveira, S, i dr.
Izdano: (2012)

AMP-activated protein kinase phosphorylates cardiac troponin I and alters contractility of murine ventricular myocytes.
od: Oliveira, S, i dr.
Izdano: (2012)

Changes in the cardiac metabolome caused by perhexiline treatment in a mouse model of hypertrophic cardiomyopathy.
od: Gehmlich, K, i dr.
Izdano: (2014)

Inherited cardiomyopathies.
od: Watkins, H, i dr.
Izdano: (2011)

Inherited cardiomyopathies.
od: Watkins, H, i dr.
Izdano: (2011)

Mutant muscle LIM protein C58G causes cardiomyopathy through protein depletion
od: Ehsan, M, i dr.
Izdano: (2018)

Inherited cardiomyopathies
od: Harper, A, i dr.
Izdano: (2014)

Inherited cardiomyopathies
od: Harper, A, i dr.
Izdano: (2014)

Mutation analysis of genes encoding subunits of AMP-activated protein kinase (AMPK) in inherited cardiomyopathies
od: Blair, E, i dr.
Izdano: (2002)

Mutation analysis of genes encoding Subunits of AMP-activated protein kinase (AMPK) in inherited cardiomyopathies
od: Oliveira, M, i dr.
Izdano: (2002)

Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletion.
od: Ashrafian, H, i dr.
Izdano: (2003)

Cardiomyopathies
od: Chan, K, i dr.
Izdano: (2018)

Myoglobin is involved in vasodilatation by nitrite
od: Ormerod, J, i dr.
Izdano: (2009)

MiR-184 expression is regulated by AMPK in pancreatic islets
od: Martinez-Sanchez, A, i dr.
Izdano: (2017)

Potentiating mitochondrial aldehyde dehydrogenase 2 to treat post-infarction heart failure.
od: Yavari, A, i dr.
Izdano: (2014)

Fyn phosphorylates AMPK to inhibit AMPK activity and AMP-dependent activation of autophagy.
od: Yamada, E, i dr.
Izdano: (2016)

Delineating the role of adenosine monophosphate (AMP)-activated protein kinase (AMP) gamma 2 subunit in hypertrophic cardiomyopathy (HCM)
od: Grignani, R, i dr.
Izdano: (2005)

The role of vascular myoglobin in nitrite-mediated blood vessel relaxation.
od: Ormerod, J, i dr.
Izdano: (2011)

Fumarate is cardioprotective via activation of the Nrf2 antioxidant pathway.
od: Ashrafian, H, i dr.
Izdano: (2012)

Fumarate is cardioprotective via activation of the Nrf2 antioxidant pathway
od: Ashrafian, H, i dr.
Izdano: (2012)

AORTIC STENOSIS WITH IMPAIRED VENTRICULAR FUNCTION MANIFESTS IMPAIRED CARDIAC METABOLISM: IMPLICATIONS FOR PROGNOSIS AND SURGICAL INTERVENTION
od: Ashrafian, H, i dr.
Izdano: (2009)

Altered regulatory properties of human cardiac troponin I mutants that cause hypertrophic cardiomyopathy.
od: Elliott, K, i dr.
Izdano: (2000)

Hypertrophic and dilated cardiomyopathycausing mutations of troponin and alpha-tropomyosin have opposite effects on thin filament calcium binding
od: Robinson, P, i dr.
Izdano: (2007)

A revised method of troponin exchange in permeabilised cardiac trabeculae using vanadate: functional consequences of a HCM-causing mutation in troponin I.
od: Preston, L, i dr.
Izdano: (2006)

Altered inhibitory and troponin C-binding activities in cardiac troponin I mutants known to cause hypertrophic cardiomyopathy
od: Elliott, K, i dr.
Izdano: (2000)

Localization of a novel N-terminal cardiac MyBP-C binding site on myosin rod
od: King, K, i dr.
Izdano: (2007)